Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial
Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial
Erickson Torio, Ahmad Ozair, Howard M. Eisenberg, Arjun Sahgal et al.
Citations
5 citations
Journal
The Lancet Oncology
Topics
Ultrasound and Hyperthermia Applications
Field-Weighted Citation Impact (FWCI)
3.37
article
Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial
Erickson Torio, Ahmad Ozair, Howard M. Eisenberg, Arjun Sahgal, Jakob V. E. Gerstl, Alexandra J. Golby, Timothy R. Smith, Maheleth Llinas, Christopher P. Cifarelli, Christopher Douville, Chixiang Chen, Haoyu Ren, Rania A. Mekary, Kevin Henry, Adomas Bunevičius, Jason P. Sheehan, Agessandro Abrahão, Harshit Arora, Ali R. Rezai, Dheeraj Gandhi, Jeffrey Carpenter, Pavlos Anastasiadis, Chris Heyn, Anna Ball, Nir Lipsman, Zhiyuan Xu, Christopher B. Pople, Haroon Ahmad, Kullervo Hynynen, Graeme F. Woodworth, Ying Meng, Jeremi Chabros, James Perry, Chetan Bettegowda, Lily C Pham, Mary Jane Lim-Fat, Cynthia Hawkins, Nathan J. McDannold, Mary Beth Anketell
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet OncologyVol. 26(12)
Institutions
West Virginia University (US), University of Maryland, Baltimore (US), Brigham and Women's Hospital (US), Sunnybrook Health Science Centre (CA), Harvard University (US), Johns Hopkins University (US), Health Sciences Centre (CA), Blanchette Rockefeller Neurosciences Institute (US), Neurological Surgery (US), Sidney Kimmel Comprehensive Cancer Center (US), University of Virginia (US), Columbia University (US)